Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Liangbin Miao"'
Autor:
Keyang Xu, Ai Fu, Zhaoyi Li, Liangbin Miao, Zhonghan Lou, Keying Jiang, Condon Lau, Tao Su, Tiejun Tong, Jianfeng Bao, Aiping Lyu, Hiu Yee Kwan
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract The cargo content in small extracellular vesicles (sEVs) changes under pathological conditions. Our data shows that in obesity, extracellular matrix protein 1 (ECM1) protein levels are significantly increased in circulating sEVs, which is de
Externí odkaz:
https://doaj.org/article/5bdde1ac1f024822849733fcd0641e17
Autor:
Yi Wang, Jianhua Li, Wenhui Zhang, Shourong Liu, Liangbin Miao, Zhaoyi Li, Ai Fu, Jianfeng Bao, Lili Huang, Liping Zheng, Er Li, Yanjun Zhang, Jianhua Yu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionVaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an effective way of protecting individuals from severe coronavirus disease 2019 (COVID-19). However, immune responses to vaccination vary consid
Externí odkaz:
https://doaj.org/article/84464a00048b4497ad6dc3fd7e60d180
Autor:
Keyang Xu, Shourong Liu, Xu Zhao, Xiantu Zhang, Xiaoqing Fu, Yumei Zhou, Kechen Xu, Liangbin Miao, Zhaoyi Li, Yan Li, Liang Qiao, Jianfeng Bao
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss , Pp 844-849 (2019)
Background Hyperuricemia is a recognised risk factor for the development of nonalcoholic fatty liver disease (NAFLD). This study aims to investigate the therapeutic effect of resveratrol (RES) on the treatment of hyperuricemia-related NAFLD in rats a
Externí odkaz:
https://doaj.org/article/43a08084b65242a1b8db8baad2a0e90d
Autor:
Keyang Xu, Xu Zhao, Xiaoqing Fu, Kechen Xu, Zhaoyi Li, Liangbin Miao, Yan Li, Zhaobin Cai, Liang Qiao, Jianfeng Bao
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 117, Iss , Pp - (2019)
Background and aims: Hyperuricemia is a risk factor for nonalcoholic fatty liver disease (NAFLD), however, the effect of gender on the hyperuricemia-related NAFLD development remains unclear. Here, we evaluated the clinical characteristics of NAFLD p
Externí odkaz:
https://doaj.org/article/508d757266d84711a1ca9e786ebe9010
Autor:
Jianfeng, Bao, Yuan, Ouyang, Liang, Qiao, Jiahui, He, Fang, Liu, Yi, Wang, Liangbin, Miao, Ai, Fu, Zhonghan, Lou, Qian, Zang, Weiqiang, Huang, Jinsong, Huang, Zhaoyi, Li
Publikováno v:
Discovery medicine. 33(168)
Liver fibrosis is the early pathological manifestation of various chronic liver diseases (including schistosomiasis, alcoholic, viral, nonalcoholic, fatty liver, etc.), which can progress to cirrhosis and even liver cancer. Out of the 7.7 billion wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0185d171d3ae3cfb924c5cec03e9ff0
https://pubmed.ncbi.nlm.nih.gov/36274212
https://pubmed.ncbi.nlm.nih.gov/36274212
Autor:
Jianhua Li, Xiaoyan Li, Haiyan Mao, Chen Huang, Yi Sun, Liangbin Miao, Jiaxuan Li, Wanchen Song, Yanjun Zhang, Jinsong Huang, Keda Chen
Publikováno v:
Virus Research. 332:199131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dc8c900a965df9297d7e3d03fe52e33
https://doi.org/10.1016/j.virusres.2023.199131
https://doi.org/10.1016/j.virusres.2023.199131
Autor:
Jianfeng Bao, Shourong Liu, Xiao Liang, Congcong Wang, Lili Cao, Zhaoyi Li, Furong Wei, Ai Fu, Yingqiu Shi, Bo Shen, Xiaoli Zhu, Yuge Zhao, Hong Liu, Liangbin Miao, Yi Wang, Shuang Liang, Linyan Wu, Jinsong Huang, Tiannan Guo, Fang Liu
Publikováno v:
Life science alliance. 6(1)
Coronavirus disease 2019 (COVID-19) patients with liver dysfunction (LD) have a higher chance of developing severe and critical disease. The routine hepatic biochemical parameters ALT, AST, GGT, and TBIL have limitations in reflecting COVID-19–rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63f9c4987b0e29eee6c022f37c6d071
https://pubmed.ncbi.nlm.nih.gov/36261228
https://pubmed.ncbi.nlm.nih.gov/36261228
Autor:
Jianfeng Bao, Shourong Liu, Xiao Liang, Congcong Wang, Lili Cao, Zhaoyi Li, Furong Wei, Ai Fu, Yingqiu Shi, Bo Shen, Xiaoli Zhu, Yuge Zhao, Hong Liu, Liangbin Miao, Yi Wang, Shuang Liang, Linyan Wu, Jinsong Huang, Tiannan Guo, Fang Liu
Publikováno v:
Life Science Alliance; Jan2023, Vol. 6 Issue 1, p1-12, 12p
Autor:
Jianfeng Bao, Shourong Liu, Liang Qiao, Zhaoyi Li, Liangbin Miao, Xiantu Zhang, Xiaoqing Fu, Xu Zhao, Yan Li, Keyang Xu, Kechen Xu, Yumei Zhou
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss, Pp 844-849 (2019)
Background Hyperuricemia is a recognised risk factor for the development of nonalcoholic fatty liver disease (NAFLD). This study aims to investigate the therapeutic effect of resveratrol (RES) on the treatment of hyperuricemia-related NAFLD in rats a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0da94a938031c6ec137171c94b0fff
https://doi.org/10.1016/j.biopha.2018.12.039
https://doi.org/10.1016/j.biopha.2018.12.039
Autor:
Zhaobin Cai, Lin Huang, Jianfeng Bao, Yujun Tang, Jianjiang Qi, Shengyou Lin, Zhaoyi Li, Jie Bao, Jinsong Huang, Yuan Xu, Zhiyu Li, Jianchun Guo, Hui Yang, Yi Zhang, Zhijun Xie, Chengping Wen, Haiping Chen, Jing Sun, Shourong Liu, Liangbin Miao, Yunhao Xun, Li Zhang
Publikováno v:
Clinical Complementary Medicine and Pharmacology
Backgroud : The outbreak of COVID-19 has brought unprecedented perils to human health and raised public health concerns in more than two hundred countries. Safe and effective treatment scheme is needed urgently. Objective : To evaluate the effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683755ccd93236a742746ddc52b0bd3b
https://doi.org/10.1016/j.ccmp.2021.100009
https://doi.org/10.1016/j.ccmp.2021.100009